OLMA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Olema Pharmaceuticals Inc (OLMA).


$334.05M Market Cap.

As of 03/19/2025 5:00 PM ET (MRY) • Disclaimer

OLMA Market Cap. (MRY)


OLMA Shares Outstanding (MRY)


OLMA Assets (MRY)


Total Assets

$450.98M

Total Liabilities

$42.02M

Total Investments

$294.61M

OLMA Income (MRY)


Revenue

$0

Net Income

-$129.47M

Operating Expense

$142.26M

OLMA Cash Flow (MRY)


CF Operations

-$104.35M

CF Investing

-$93.53M

CF Financing

$268.82M

OLMA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

OLMA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$450,979,000 (62.84%)

$276,945,000 (28.43%)

$215,645,000 (-27.13%)

$295,945,000 (-13.65%)

Assets Current

$438,473,000 (64.52%)

$266,513,000 (27.58%)

$208,899,000 (-28.14%)

$290,685,000 (-15.04%)

Assets Non-Current

$12,506,000 (19.88%)

$10,432,000 (54.64%)

$6,746,000 (28.25%)

$5,260,000 (799.15%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$408,964,000 (61.08%)

$253,895,000 (28.52%)

$197,546,000 (-30.58%)

$284,568,000 (-15.84%)

Property Plant & Equipment Net

$1,314,000 (-42.65%)

$2,291,000 (-42.36%)

$3,975,000 (-15.78%)

$4,720,000 (6193.33%)

Cash & Equivalents

$139,480,000 (103.50%)

$68,539,000 (189.17%)

$23,702,000 (71.60%)

$13,812,000 (-95.92%)

Accumulated Other Comprehensive Income

$143,000 (-58.79%)

$347,000 (119.14%)

-$1,813,000 (-1116.78%)

-$149,000 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$294,606,000 (52.43%)

$193,268,000 (6.94%)

$180,719,000 (-33.91%)

$273,438,000 (0%)

Investments Current

$294,606,000 (52.43%)

$193,268,000 (6.94%)

$180,719,000 (-33.91%)

$273,438,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$4,460,000 (65.31%)

$2,698,000 (621.39%)

$374,000 (1526.09%)

$23,000 (-96.80%)

Accumulated Retained Earnings (Deficit)

-$435,106,000 (-42.36%)

-$305,632,000 (-46.25%)

-$208,977,000 (-100.57%)

-$104,190,000 (-214.83%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,429,000 (-40.88%)

$2,417,000 (-5.77%)

$2,565,000 (-22.01%)

$3,289,000 (0%)

Debt Current

$1,172,000 (18.62%)

$988,000 (-2.66%)

$1,015,000 (9.02%)

$931,000 (0%)

Debt Non-Current

$257,000 (-82.02%)

$1,429,000 (-7.81%)

$1,550,000 (-34.27%)

$2,358,000 (0%)

Total Liabilities

$42,015,000 (82.28%)

$23,050,000 (27.36%)

$18,099,000 (59.08%)

$11,377,000 (148.14%)

Liabilities Current

$41,758,000 (93.14%)

$21,621,000 (30.65%)

$16,549,000 (83.49%)

$9,019,000 (96.71%)

Liabilities Non-Current

$257,000 (-82.02%)

$1,429,000 (-7.81%)

$1,550,000 (-34.27%)

$2,358,000 (0%)

OLMA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$17,741,000 (-5.74%)

$18,821,000 (-23.84%)

$24,714,000 (21.20%)

$20,391,000 (160.62%)

Research & Development Expense

$124,517,000 (44.55%)

$86,140,000 (4.70%)

$82,274,000 (61.01%)

$51,100,000 (272.88%)

Operating Expenses

$142,258,000 (35.53%)

$104,961,000 (-1.89%)

$106,988,000 (49.65%)

$71,491,000 (232.08%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$129,474,000 (-33.95%)

-$96,655,000 (7.76%)

-$104,787,000 (-47.39%)

-$71,096,000 (-221.40%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$129,474,000 (-33.95%)

-$96,655,000 (7.76%)

-$104,787,000 (-47.39%)

-$71,096,000 (-221.40%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$129,474,000 (-33.95%)

-$96,655,000 (7.76%)

-$104,787,000 (-47.39%)

-$71,096,000 (-196.36%)

Weighted Average Shares

$58,743,522 (29.83%)

$45,247,098 (13.13%)

$39,995,460 (1.19%)

$39,524,272 (462.91%)

Weighted Average Shares Diluted

$58,743,522 (29.83%)

$45,247,098 (13.13%)

$39,995,460 (1.19%)

$39,524,272 (462.91%)

Earning Before Interest & Taxes (EBIT)

-$129,474,000 (-33.95%)

-$96,655,000 (7.76%)

-$104,787,000 (-47.39%)

-$71,096,000 (-231.17%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$142,258,000 (-35.53%)

-$104,961,000 (1.89%)

-$106,988,000 (-49.65%)

-$71,491,000 (-232.08%)

OLMA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$93,526,000 (-1827.97%)

-$4,851,000 (-105.30%)

$91,479,000 (133.21%)

-$275,438,000 (-491753.57%)

Net Cash Flow from Financing

$268,818,000 (101.49%)

$133,415,000 (27928.36%)

$476,000 (-65.78%)

$1,391,000 (-99.61%)

Net Cash Flow from Operations

-$104,351,000 (-24.63%)

-$83,727,000 (-2.03%)

-$82,065,000 (-61.90%)

-$50,690,000 (-155.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

$70,941,000 (58.22%)

$44,837,000 (353.36%)

$9,890,000 (103.05%)

-$324,737,000 (-195.94%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$93,367,000 (-1819.16%)

-$4,865,000 (-105.30%)

$91,842,000 (133.54%)

-$273,863,000 (0%)

Capital Expenditure

-$159,000 (-1235.71%)

$14,000 (103.86%)

-$363,000 (76.95%)

-$1,575,000 (-2712.50%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$268,818,000 (101.49%)

$133,415,000 (27928.36%)

$476,000 (-65.78%)

$1,391,000 (-99.37%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$22,582,000 (30.86%)

$17,256,000 (-8.35%)

$18,829,000 (18.32%)

$15,913,000 (412.00%)

Depreciation Amortization & Accretion

$1,543,000 (-7.83%)

$1,674,000 (0.97%)

$1,658,000 (19.54%)

$1,387,000 (12509.09%)

OLMA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-48.30% (-8.05%)

-44.70% (2.19%)

-45.70% (-96.98%)

-23.20% (-58.90%)

Return on Average Assets (ROAA)

-43.20% (-5.37%)

-41.00% (4.65%)

-43.00% (-90.27%)

-22.60% (-61.43%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-60.50% (3.20%)

-62.50% (-25.00%)

-50.00% (-92.31%)

-26.00% (-101.05%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.65 (59.58%)

-6.56 (-601.18%)

-0.94 (82.02%)

-5.2 (63.01%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.82 (-73.01%)

3.03 (502.99%)

0.5 (-62.11%)

1.32 (-75.16%)

Debt to Equity Ratio (D/E)

0.1 (13.19%)

0.09 (-1.09%)

0.09 (130.00%)

0.04 (185.71%)

Earnings Per Share (EPS)

-2.2 (-2.80%)

-2.14 (18.32%)

-2.62 (-45.56%)

-1.8 (47.37%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.78 (3.84%)

-1.85 (10.24%)

-2.06 (-55.90%)

-1.32 (53.40%)

Book Value Per Share (BVPS)

6.96 (24.08%)

5.61 (13.61%)

4.94 (-31.40%)

7.2 (-85.05%)

Tangible Assets Book Value Per Share (TABVPS)

7.68 (25.42%)

6.12 (13.52%)

5.39 (-27.99%)

7.49 (-84.66%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (71.43%)

-7 (-600.00%)

-1 (80.00%)

-5 (93.59%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.34 (65.94%)

-6.88 (-844.03%)

-0.73 (85.54%)

-5.04 (93.55%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

10.5 (-14.82%)

12.33 (-2.34%)

12.62 (-60.83%)

32.23 (-56.81%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$104,510,000 (-24.84%)

-$83,713,000 (-1.56%)

-$82,428,000 (-57.71%)

-$52,265,000 (-162.35%)

Enterprise Value (EV)

$299,857,436 (-54.12%)

$653,636,294 (769.87%)

$75,141,796 (-78.62%)

$351,495,320 (-79.03%)

Earnings Before Tax (EBT)

-$129,474,000 (-33.95%)

-$96,655,000 (7.76%)

-$104,787,000 (-47.39%)

-$71,096,000 (-221.40%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$127,931,000 (-34.69%)

-$94,981,000 (7.90%)

-$103,129,000 (-47.94%)

-$69,709,000 (-224.88%)

Invested Capital

$271,170,000 (43.32%)

$189,202,000 (6.32%)

$177,959,000 (-35.62%)

$276,403,000 (67188.11%)

Working Capital

$396,715,000 (62.00%)

$244,892,000 (27.32%)

$192,350,000 (-31.71%)

$281,666,000 (-16.56%)

Tangible Asset Value

$450,979,000 (62.84%)

$276,945,000 (28.43%)

$215,645,000 (-27.13%)

$295,945,000 (-13.65%)

Market Capitalization

$334,046,436 (-56.53%)

$768,420,294 (675.28%)

$99,115,796 (-73.72%)

$377,092,320 (-79.10%)

Average Equity

$267,839,000 (23.77%)

$216,396,750 (-5.57%)

$229,154,500 (-25.21%)

$306,392,500 (87.09%)

Average Assets

$299,850,750 (27.17%)

$235,784,000 (-3.33%)

$243,915,000 (-22.52%)

$314,817,750 (83.65%)

Invested Capital Average

$213,876,250 (38.25%)

$154,706,250 (-26.25%)

$209,766,250 (-23.27%)

$273,376,250 (31777.43%)

Shares

57,297,845 (4.62%)

54,769,800 (35.38%)

40,455,427 (0.42%)

40,287,641 (7.38%)